ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,052, issued on May 12, was assigned to QUANTA THERAPEUTICS INC. (South San Francisco, Calif.).
"KRAS modulators and uses thereof" was invented by Hong Lin (Exton, Pa.), Juan Luengo (Phoenixville, Pa.), Neil Johnson (Downingtown, Pa.) and Audrey Hospital (Robbinsville, N.J.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are KRAS modulating compounds, such as compounds of Formula (I), (II) (II*) (III) or pharmaceutically acceptable salts, solvates, stereoisomers, atom labelled, or tautomers of any of the foregoing, useful for modulating KRAS GD12 and/or other G12 mutants."
The patent was filed on Jan. 16, 2024, under Application No. 18...